Latest & Local News

Put text on photo, Blur faces in photos,
Image editing and more...

Gilead news

Gilead Reports Promising CAR-T Therapy Results for Glioblastoma Treatment - geneonline.com

Gilead Reports Promising CAR-T Therapy Results for Glioblastoma Treatment geneonline.com

Published on 7 June 2025 | 8:05 pm

Gilead Sciences Reports Promising Early Results for CAR-T Therapy in Treating Glioblastoma - geneonline.com

Gilead Sciences Reports Promising Early Results for CAR-T Therapy in Treating Glioblastoma geneonline.com

Published on 6 June 2025 | 3:45 pm

At 150, this historic Fort Worth church is falling apart. Can it be saved? - Fort Worth Star-Telegram

At 150, this historic Fort Worth church is falling apart. Can it be saved? Fort Worth Star-Telegram

Published on 6 June 2025 | 3:40 pm

Gilead Sciences: Advancing New Ways To Help End the HIV - CSRwire

Gilead Sciences: Advancing New Ways To Help End the HIV CSRwire

Published on 6 June 2025 | 2:33 pm

Gilead Eyes FDA Nod for Long-Acting HIV Drug - Gilead Sciences (NASDAQ:GILD) - Benzinga

Gilead Eyes FDA Nod for Long-Acting HIV Drug - Gilead Sciences (NASDAQ:GILD) Benzinga

Published on 5 June 2025 | 5:09 pm

Gilead Sciences: Advancing New Ways To Help End the HIV Epidemic Is the Focus of This Installment of "The Centrifuge Sessions" - marketscreener.com

Gilead Sciences: Advancing New Ways To Help End the HIV Epidemic Is the Focus of This Installment of "The Centrifuge Sessions" marketscreener.com

Published on 5 June 2025 | 1:37 pm

Gilead Sciences: Advancing New Ways To Help End the HIV Epidemic Is the Focus of This Installment of "The Centrifuge Sessions" - ACCESS Newswire

Gilead Sciences: Advancing New Ways To Help End the HIV Epidemic Is the Focus of This Installment of "The Centrifuge Sessions" ACCESS Newswire

Published on 5 June 2025 | 1:21 pm

A New Shot Prevents HIV—and Breathes New Life Into a Stagnant Biotech - WSJ

A New Shot Prevents HIV—and Breathes New Life Into a Stagnant Biotech WSJ

Published on 5 June 2025 | 9:30 am

Is Gilead Sciences Stock Outperforming the S&P 500? - MSN

Is Gilead Sciences Stock Outperforming the S&P 500? MSN

Published on 4 June 2025 | 4:22 pm

Gilead Gears Up To Challenge J&J in $20B Multiple Myeloma CAR-T Market - BioSpace

Gilead Gears Up To Challenge J&J in $20B Multiple Myeloma CAR-T Market BioSpace

Published on 4 June 2025 | 4:09 am

Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO - CNBC

Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO CNBC

Published on 3 June 2025 | 7:34 pm

Mount Gilead community rallies to support slain deputy’s family, friends - nbc4i.com

Mount Gilead community rallies to support slain deputy’s family, friends nbc4i.com

Published on 3 June 2025 | 3:16 am

ASCO25: CAR-Ts from Allogene, Gilead show early promise in solid tumours - FirstWord Pharma

ASCO25: CAR-Ts from Allogene, Gilead show early promise in solid tumours FirstWord Pharma

Published on 3 June 2025 | 2:52 am

Beyond Blood Cancers: New Explorations in CAR T-cell Therapy - Gilead Sciences

Beyond Blood Cancers: New Explorations in CAR T-cell Therapy Gilead Sciences

Published on 2 June 2025 | 5:48 pm

Gilead Sciences Commemorated the Opening of the Bay Area Young Survivors Breast Cancer Memorial Garden - CSRwire

Gilead Sciences Commemorated the Opening of the Bay Area Young Survivors Breast Cancer Memorial Garden CSRwire

Published on 2 June 2025 | 2:01 pm

Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial - Reuters

Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial Reuters

Published on 2 June 2025 | 9:05 am

FDA Action Alert: Merck, Moderna, Gilead, Regeneron/Sanofi and More - BioSpace

FDA Action Alert: Merck, Moderna, Gilead, Regeneron/Sanofi and More BioSpace

Published on 2 June 2025 | 4:06 am

Gilead's CAR-T cell therapy shows promise in deadly brain cancer - Reuters

Gilead's CAR-T cell therapy shows promise in deadly brain cancer Reuters

Published on 1 June 2025 | 12:02 pm

ASCO: Kite's CAR-T passes lymphoma safety trial with flying colors - Fierce Biotech

ASCO: Kite's CAR-T passes lymphoma safety trial with flying colors Fierce Biotech

Published on 31 May 2025 | 11:00 pm

ASCO day 2: A tragic paradox, Gilead updates, and lots of Pfizer news - statnews.com

ASCO day 2: A tragic paradox, Gilead updates, and lots of Pfizer news statnews.com

Published on 31 May 2025 | 9:14 pm

ASCO: Gilead bolsters Trodelvy in triple-negative breast cancer with practice-changing Keytruda combo win - Fierce Pharma

ASCO: Gilead bolsters Trodelvy in triple-negative breast cancer with practice-changing Keytruda combo win Fierce Pharma

Published on 31 May 2025 | 7:00 am

Gilead Sciences Commemorated the Opening of the Bay Area Young Survivors Breast Cancer Memorial Garden - Yahoo Finance

Gilead Sciences Commemorated the Opening of the Bay Area Young Survivors Breast Cancer Memorial Garden Yahoo Finance

Published on 30 May 2025 | 7:00 am

Gilead commits to HIV prevention rollout for low-income countries despite funding uncertainty - Reuters

Gilead commits to HIV prevention rollout for low-income countries despite funding uncertainty Reuters

Published on 30 May 2025 | 7:00 am

How 'The Handmaid's Tale' ends after 6 years in Gilead: Does June live? - USA Today

How 'The Handmaid's Tale' ends after 6 years in Gilead: Does June live? USA Today

Published on 27 May 2025 | 7:00 am

After Keytruda combo win, Gilead's Trodelvy meets the mark in solo breast cancer trial - Fierce Pharma

After Keytruda combo win, Gilead's Trodelvy meets the mark in solo breast cancer trial Fierce Pharma

Published on 23 May 2025 | 7:00 am

Gilead pays partner Hookipa $10M to take over HBV, HIV therapeutic vaccine programs - Fierce Biotech

Gilead pays partner Hookipa $10M to take over HBV, HIV therapeutic vaccine programs Fierce Biotech

Published on 22 May 2025 | 7:00 am

Gilead Sciences, Inc. (GILD) and Kite to Present Breakthrough Cancer Therapy Data at 2025 ASCO and EHA - Yahoo Finance

Gilead Sciences, Inc. (GILD) and Kite to Present Breakthrough Cancer Therapy Data at 2025 ASCO and EHA Yahoo Finance

Published on 18 May 2025 | 7:00 am

Gilead and Kite Announce Presentation of Transformative Data in 1L Metastatic Triple-Negative Breast Cancer, Updated Results in Multiple Myeloma and Early Data From Novel Investigational CAR T-Cell Therapy Targeting Brain Cancer at 2025 ASCO and E - Business Wire

Gilead and Kite Announce Presentation of Transformative Data in 1L Metastatic Triple-Negative Breast Cancer, Updated Results in Multiple Myeloma and Early Data From Novel Investigational CAR T-Cell Therapy Targeting Brain Cancer at 2025 ASCO and E Business Wire

Published on 15 May 2025 | 7:00 am

Why Gilead Sciences (GILD) Is Among the Best Pharma Stocks to Invest in Amid the Domestic Manufacturing Boom - Yahoo Finance

Why Gilead Sciences (GILD) Is Among the Best Pharma Stocks to Invest in Amid the Domestic Manufacturing Boom Yahoo Finance

Published on 13 May 2025 | 7:00 am

Gilead reports final outcomes from trial of bulevirtide for chronic HDV - Clinical Trials Arena

Gilead reports final outcomes from trial of bulevirtide for chronic HDV Clinical Trials Arena

Published on 8 May 2025 | 7:00 am

Gilead, bracing for tariffs, joins peers in US drug production push - BioPharma Dive

Gilead, bracing for tariffs, joins peers in US drug production push BioPharma Dive

Published on 8 May 2025 | 7:00 am

Gilead tees up $11B in new US manufacturing, R&D investments - Fierce Pharma

Gilead tees up $11B in new US manufacturing, R&D investments Fierce Pharma

Published on 8 May 2025 | 7:00 am

Gilead Pumps $11B More Into US Manufacturing, Hopes To Add 3,000 Jobs - BioSpace

Gilead Pumps $11B More Into US Manufacturing, Hopes To Add 3,000 Jobs BioSpace

Published on 8 May 2025 | 7:00 am

Gilead Sciences Increases Investment in U.S. Operations - Contract Pharma

Gilead Sciences Increases Investment in U.S. Operations Contract Pharma

Published on 8 May 2025 | 7:00 am

Gilead boosts planned US investments by $11 billion amid tariff threat - Reuters

Gilead boosts planned US investments by $11 billion amid tariff threat Reuters

Published on 7 May 2025 | 7:00 am

Speaker Program Settlement Highlights Compliance Risks for Life Sciences Companies - Skadden, Arps, Slate, Meagher & Flom LLP

Speaker Program Settlement Highlights Compliance Risks for Life Sciences Companies Skadden, Arps, Slate, Meagher & Flom LLP

Published on 6 May 2025 | 7:00 am

Gilead enters $202M settlement to resolve US government's long-running HIV kickbacks probe - Fierce Pharma

Gilead enters $202M settlement to resolve US government's long-running HIV kickbacks probe Fierce Pharma

Published on 29 April 2025 | 7:00 am

Gilead to Present Latest Advancements Across Primary Biliary Cholangitis and Viral Hepatitis - Business Wire

Gilead to Present Latest Advancements Across Primary Biliary Cholangitis and Viral Hepatitis Business Wire

Published on 29 April 2025 | 7:00 am

Gilead to pay $202 million to settle doctor kickback claims related to HIV drug prescriptions - CNBC

Gilead to pay $202 million to settle doctor kickback claims related to HIV drug prescriptions CNBC

Published on 29 April 2025 | 7:00 am

Gilead Sciences to pay $202 million in US settlement over HIV drug kickbacks - Reuters

Gilead Sciences to pay $202 million in US settlement over HIV drug kickbacks Reuters

Published on 29 April 2025 | 7:00 am

Gilead Sciences to Present at Upcoming Investor Conferences - Business Wire

Gilead Sciences to Present at Upcoming Investor Conferences Business Wire

Published on 29 April 2025 | 7:00 am